The nutritional supplement N-acetylcysteine (NAC) may have immunomodulatory and cardioprotective properties, which can potentially benefit pulmonary hypertension patients, according…
Articles by Patrícia Silva, PhD
The Pulmonary Hypertension Association (PHA) is hosting the 2014 International PH Conference and Scientific Sessions, in what…
For those with PAH, treating inflammation associated with the disease could be the next step in improving quality of…
Team PHenomenal Hope is one of the cycling teams that is set compete in a high-endurance cycling event called Race Across…
Bayer HealthCare recently announced it will test the efficacy and safety of the drug Riociguat in patients with symptomatic…
Last Tuesday, May 13, 2014, the U.S. Food and Drug Administration, together with the Pulmonary Hypertension Association, held a…
According to recent data, there is a direct correlation between pulmonary emboli that result in the onset of pulmonary…
Bayer HealthCare, a subsidiary of German-owned corporation, Bayer AG, has just announced that it has registered its therapeutic drug…
Bayer Healthcare recently announced the approval of its novel drug Adempas (riociguat), which has been listed by the Régie de…
There is a basic difference between pulmonary arterial hypertension (PAH) in adults and in children. In the former case,…
Pulmonary Arterial Hypertension (PAH) is a frequently encountered complication of Systemic Sclerosis (SSc). PAH is also the leading cause…
A group of researchers led by Dr. Sophie Grigoriadis, MD, PhD, head of the women’s mood and anxiety clinic…